Stem Cells from Skin Cells

Success may help erase practical hurdles—if not ethical ones—to cloning human embryonic stem cells to study and treat degenerative disorders















Share on Tumblr

reprogrammed cells

GET WITH THE PROGRAM: In one of two new techniques that may lower the barriers to growing embryonic stem cells, three teams reprogrammed mouse skin cells to enter an embryonic state [above]. Image: MARIUS WERNIG AND ALEXANDER MEISSNER

  • What a Plant Knows

    How does a Venus flytrap know when to snap shut? Can it actually feel an insect’s tiny, spindly legs? And how do cherry blossoms know when to bloom? Can they...

    Read More »

Two methods for creating embryonic stem cells just got a big boost. In one development, three teams of scientists report they have turned back the clock on mouse skin cells, changing them into embryolike cells by introducing a cocktail of four genes. "You can now basically reverse development in a culture dish," says Marius Wernig of the Massachusetts Institute of Technology's Whitehead Institute for Biomedical Research, a member of one of the teams.

If extended to humans, the technique would allow researchers to create potentially all-purpose stem cells without using embryos. However, experts say they will still have to study cells from human embryos to figure out how to make the jump to humans and, beyond that, how the two kinds of cell would stack up as ways of regenerating diseased tissue.

In a second approach, a group of researchers successfully cloned mice from fertilized embryos instead of unfertilized eggs. Because fertilized human embryos are far more accessible than unfertilized eggs, which cannot be frozen and stored, extending the result to humans could lower the practical barriers against creating human embryonic stem cells to study and potentially treat disease.

Neither technique works outside of mice yet, but researchers are optimistic they can apply at least some of the findings to human cells. "There's good reason to believe the rules will be the same" for human and mouse cells, says stem cell biologist Kevin Eggan of the Harvard Stem Cell Institute (HSCI).

Both studies hinge on the concept of nuclear reprogramming, or removing the molecular changes that keep adult DNA from returning to the embryonic state. The traditional way to reprogram a cell is to remove its nucleus, which contains the DNA, and inject it into an unfertilized egg that has had its own nucleus removed—in other words, cloning. Cloning researchers had thought that only unfertilized eggs were capable of reprogramming adult DNA.

Stem Cells Sans Embryos

Imagine researchers' excitement, then, when Kyoto University's Shinya Yamanaka reported last year that his group had created embryolike cells directly, without transferring chromosomes, simply by injecting mouse fibroblast cells with four genes that are active in embryonic cells but not in adult ones. The reprogrammed cells did not contribute to adult tissues when injected into embryos, however, which is the hallmark of embryonic cells.

Three groups—those of Yamanaka, Whitehead's Rudolf Jaenisch and Konrad Hochedlinger of the HSCI—report they have independently surmounted that obstacle by selecting reprogrammed cells that produced molecules more characteristic of embryonic cells. When harvested after several weeks and injected into blastocysts, the cells contributed to all three of the embryo's layers and in some cases turned up in the offspring of blastocysts that reached adulthood.

The reprogrammed cells are "almost indistinguishable" from embryonic cells, says stem cell researcher Alex Meissner, part of the Whitehead team, which has published its results online today in Nature alongside those of Yamanaka's group.

The next step is to see if the process works and is safe in human cells. "If we're lucky and it's just the [same] four factors, it will be very quick [to happen] in humans," Meissner says. But researchers will have to figure out how to eliminate the viral DNA used to introduce the genes, which in Yamanaka's experiments led to cancers in 20 percent of mice grown from blastocysts.

Ethicist Nigel Cameron of the Illinois Institute of Technology, an opponent of embryonic stem cell research, praises the reprogramming findings. But Hochedlinger, whose group's paper appears in a new journal called Cell Stem Cell, stresses that researchers still need to study human cells to learn how to reprogram them and have no idea yet which approach would work better in the long run.

"It would be a big mistake," Meissner notes, "to say, 'now we can generate these [reprogrammed] cells, [so] we have to stop all human embryonic stem cell research.'"



1 Comments

Add Comment
View
  1. 1. Paramedic851 04:26 AM 12/15/08

    lets go, save some lives already

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

More »

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital

Latest from SA Blog Network

  SA Digital

Science Jobs of the Week

Email this Article

Stem Cells from Skin Cells

X
Scientific American Magazine

Subscribe Today

Save 66% off the cover price and get a free gift!

Learn More >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X